Blue Trust Inc’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-164
Closed -$2K 2799
2023
Q4
$2K Buy
164
+27
+20% +$331 ﹤0.01% 2246
2023
Q3
$2K Buy
+137
New +$1.8K ﹤0.01% 1873
2023
Q2
Sell
-1,345
Closed -$24K 2636
2023
Q1
$24K Buy
1,345
+139
+12% +$2.25K ﹤0.01% 1312
2022
Q4
$18K Buy
1,206
+513
+74% +$8.6K ﹤0.01% 1337
2022
Q3
$10K Buy
693
+22
+3% +$356 ﹤0.01% 1356
2022
Q2
$15K Buy
+671
New +$12.5K ﹤0.01% 1080

Other funds holding MDRX

Blue Trust Inc's MDRX Position: Q1 2024 in Review

Blue Trust Inc sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 164 shares — an estimated $2K sold.

Blue Trust Inc first reported a position in MDRX in Q2 2022 and held it in 6 quarters. The position peaked at $24K in Q1 2023. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Blue Trust Inc reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Blue Trust Inc sold 164 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $2K.
  • Blue Trust Inc first reported a position in Veradigm Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Blue Trust Inc's Veradigm Inc. Common Stock position peaked at $24K in Q1 2023.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Blue Trust Inc's 13F filing for Q1 2024, filed 1 May 2024.